Analysts Estimations: Stock in Focus Today: Container Store Group Inc (NYSE:TCS)

The shares of Container Store Group Inc (NYSE:TCS) currently has mean rating of 3.00 while Zero analysts have recommended the shares as “BUY”, Zero recommended as “OUTPERFORM” and 6 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending May-16 is 848.70 million by 5 analysts. The means estimate of sales for the year ending Mar-16 is 848.70 million by 5 analysts.

The mean price target for the shares of Container Store Group Inc (NYSE:TCS) is at 6.67 while the highest price target suggested by the analysts is 7.50 and low price target is 6.00. The mean price target is calculated keeping in view the consensus of 3 brokerage firms.

The next one year’s EPS estimate is set at 0.25 by 5 analysts. The analysts also projected the company’s long-term growth at -20.72% for the upcoming five years.

In its latest quarter ended on 30th Feb 2016, Container Store Group Inc (NYSE:TCS) reported earnings of $0.20. The posted earnings missed the analyst’s consensus by -$0.01 with the surprise factor of -4.80%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 17, 2016 Container Store Group Inc (TCS) announces a new summer festival, and Starbucks and Teavana find a generous way to celebrate National Iced Tea Day. Watch the full episode for more stories featuring The Container Store, Apple, Nintendo, Sling, and Bread for the World on BizWireTV – now featuring the Top Five Most-Shared Stories of the Week.

Stock to Watch: American Assets Trust, Inc (NYSE:AAT)

The shares of American Assets Trust, Inc (NYSE:AAT) currently has mean rating of 2.14 while 2 analysts have recommended the shares as “BUY”, 2 recommended as “OUTPERFORM” and 3 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 72.09 million by 4 analysts. The means estimate of sales for the year ending Dec-16 is 293.19 million by 6 analysts.

The mean price target for the shares of American Assets Trust, Inc (NYSE:AAT) is at 46.25 while the highest price target suggested by the analysts is 49.00 and low price target is 42.00. The mean price target is calculated keeping in view the consensus of 4 brokerage firms.

The average estimate of EPS for the current fiscal quarter for American Assets Trust, Inc (NYSE:AAT) stands at 0.46 while the EPS for the current year is fixed at 1.88 by 7 analysts.

The next one year’s EPS estimate is set at 2.09 by 7 analysts while a year ago the analysts suggested the company’s EPS at 1.88. The analysts also projected the company’s long-term growth at 3.00% for the upcoming five years.

In its latest quarter ended on 31st March 2016, American Assets Trust, Inc (NYSE:AAT) reported earnings of $0.45. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On April 26, 2016 American Assets Trust, Inc (AAT) reported financial results for its first quarter ended March 31, 2016.

Financial Results and Recent Developments

  • Funds From Operations increased 5% year-over-year to $0.45 per diluted share for the three months ended March 31, 2016 compared to the same period in 2015
  • Net income available to common stockholders of $7.7 million for the three months ended March 31, 2016, or $0.17 per diluted share
  • Same-store cash and GAAP NOI increased 7% and 5%, respectively, for the three months ended March 31, 2016 compared to the same period in 2015
  • Entered into a new $100 million seven-year unsecured term loan with an interest rate fixed at approximately 3.15% (subject to adjustments based on our consolidated leverage ratio) as a result of an interest rate swap
  • Leased approximately 52,100 comparable office square feet at an average cash-basis and GAAP-basis contractual rent increase of 9% and 18%, respectively, during the three months ended March 31, 2016
  • Leased approximately 81,100 comparable retail square feet at an average cash-basis and GAAP-basis contractual rent increase of 2% and 9%, respectively, during the three months ended March 31, 2016

During the first quarter of 2016, the company generated funds from operations (“FFO”) for common stockholders of $28.1 million, or $0.45 per diluted share, compared to $26.4 million, or $0.43 per diluted share, for the quarter ended March 31, 2015. The increase in FFO from the corresponding period in 2015 was primarily due to additional operating income from Hassalo on Eighth and growth in same-store net operating income from our existing portfolio.

Net income attributable to common stockholders was $7.7 million, or $0.17 per basic and diluted share for the three months ended March 31, 2016 compared to $8.0 million, or $0.18 per basic and diluted share for the three months ended March 31, 2015. The decrease in net income attributable to common stockholders from the corresponding period in 2015 was primarily due to an increase in depreciation and amortization expense and interest expense during the three months ended March 31, 2016 attributed to the completion of Hassalo on Eighth, which was completed during the third and fourth quarters of 2015.

FFO is a non-GAAP supplemental earnings measure which the company considers meaningful in measuring its operating performance.   A reconciliation of FFO to net income is attached to this press release.

What Analysts say about Conn’s Inc (NASDAQ:CONN)?

The shares of Conn’s Inc (NASDAQ:CONN) currently has mean rating of 2.57 while 1 analysts have recommended the shares as “BUY”, 1 recommended as “OUTPERFORM” and 5 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jul-16 is 417.71 million by 5 analysts. The means estimate of sales for the year ending Jan-17 is 1.69 million by 6 analysts.

The mean price target for the shares of Conn’s Inc (NASDAQ:CONN) is at 13.17 while the highest price target suggested by the analysts is 16.00 and low price target is 8.50. The mean price target is calculated keeping in view the consensus of 3 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Conn’s Inc (NASDAQ:CONN) stands at -0.03 while the EPS for the current year is fixed at -0.14 by 6 analysts.

The next one year’s EPS estimate is set at 0.52 by 6 analysts while a year ago the analysts suggested the company’s EPS at -0.14. The analysts also projected the company’s long-term growth at 23.00% for the upcoming five years.

In its latest quarter ended on 30th Apr 2016, Conn’s Inc (NASDAQ:CONN) reported earnings of -$0.31. The posted earnings missed the analyst’s consensus by -$0.37 with the surprise factor of -616.70%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 7, 2016 Conn’s Inc (CONN) reported $111.0 million in total retail net sales for the month ended May 31, 2016, a 0.8% increase compared to the same prior year period.

Norm Miller, Conn’s Chairman, Chief Executive Officer and President, commented, “During May, same store sales declined by 6.7%, excluding the impact of our April 2015 decision to exit video game products, digital cameras, and certain tablets. Sales compared to the prior year were driven by two factors. First, underwriting refinements implemented during the fourth quarter of fiscal 2016 and in the first quarter of fiscal 2017 reduced sales by approximately 650 to 700 basis points, consistent with our expectations. These changes are expected to reduce credit risk and improve future portfolio performance. Second, Memorial Day fell five days later this year. As a result, more of the sales written over the holiday weekend will not be delivered and booked until June than in the prior year. This affected same store sales by an estimated 290 basis points.

“Furniture sales continued to trend better than the Company average on increased advertising exposure. Excluding sales of exited products, same store sales of consumer electronics were down 13.3% on softer vendor promotions on televisions compared to the prior year, with some recovery late in the month on aggressive Memorial Day promotions by the manufacturers. Home office sales were down 1.6%, excluding sales of exited products.

“Greater than 60-day delinquency was 8.9% as of May 31, 2016, a sequential increase from 8.6% as of April 30, 2016, and compared to 8.5% as of May 31, 2015. Continued reductions in the pace of portfolio growth are negatively impacting the year-over-year delinquency rate comparison.”

All of the above May 31, 2016 amounts are preliminary estimates and are subject to change upon completion of the Company’s financial statement closing process. The Company has provided monthly same store sales, portfolio balance and 60-plus day delinquency rate data for all monthly periods since and including February 2012 on its investor relations website at ir.conns.com.

Technical Analysis: Intellia Therapeutics Inc (NASDAQ:NTLA)

The shares of Intellia Therapeutics Inc (NASDAQ:NTLA) currently has mean rating of 2.25 while 1 analysts have recommended the shares as “BUY”, 1 recommended as “OUTPERFORM” and 2 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 6.56 million by 4 analysts. The means estimate of sales for the year ending Dec-16 is 20.59 million by 4 analysts.

The mean price target for the shares of Intellia Therapeutics Inc (NASDAQ:NTLA) is at 35.50 while the highest price target suggested by the analysts is 39.00 and low price target is 32.00. The mean price target is calculated keeping in view the consensus of 4 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Intellia Therapeutics Inc (NASDAQ:NTLA) stands at -0.10 while the EPS for the current year is fixed at -0.63 by 4 analysts.

The next one year’s EPS estimate is set at -0.93 by 4 analysts while a year ago the analysts suggested the company’s EPS at -0.63.

In its latest quarter ended on 31st March 2016, Intellia Therapeutics Inc (NASDAQ:NTLA) reported earnings of -$9.89. The posted earnings missed the analyst’s consensus by -$9.61 with the surprise factor of -3432.10%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Intellia Therapeutics Inc., a gene editing company, focuses on the development of therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism; and ex vivo applications of the technology in chimeric antigen receptor T cell and hematopoietic stem cell product candidates. It has a strategic collaboration and license agreement with Novartis focused on the development of new ex vivo CRISPR/Cas9-based therapies. Intellia Therapeutics Inc. was formerly known as AZRN, Inc. and changed its name to Intellia Therapeutics Inc. in July 2014. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Astoria Financial Corp (NYSE:AF)

The shares of Astoria Financial Corp (NYSE:AF) currently has mean rating of 2.75 while 1 analysts have recommended the shares as “BUY”, 1 recommended as “OUTPERFORM” and 5 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 87.66 million by 3 analysts. The means estimate of sales for the year ending Dec-16 is 350.64 million by 3 analysts.

The mean price target for the shares of Astoria Financial Corp (NYSE:AF) is at 16.11 while the highest price target suggested by the analysts is 20.00 and low price target is 13.50. The mean price target is calculated keeping in view the consensus of 190 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Astoria Financial Corp (NYSE:AF) stands at 0.16 while the EPS for the current year is fixed at 0.61 by 5 analysts.

The next one year’s EPS estimate is set at 0.59 by 5 analysts while a year ago the analysts suggested the company’s EPS at 0.61. The analysts also projected the company’s long-term growth at 5.00% for the upcoming five years.

In its latest quarter ended on 31st March 2016, Astoria Financial Corp (NYSE:AF) reported earnings of $0.16. The posted earnings topped the analyst’s consensus by $0.01 with the surprise factor of 6.70%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 2, 2016 Astoria Financial Corp (AF) announced it will continue its support as the lead sponsor for the Fourth of July Fireworks celebration at Jones Beach – officially titled Astoria Bank July 4th Fireworks at Jones Beach. Astoria’s commitment helps make possible this decades-long tradition for Long Islanders and visitors from throughout the New York Metropolitan region.

“Astoria Bank is honored to have the opportunity to once again host the Fourth of July Fireworks at Jones Beach this summer,” said Astoria Bank CEO and President Monte Redman. “We are thrilled to bring families and friends together for this special holiday event and are excited to once again be at Jones Beach, celebrating with our customers and the communities we serve.”

The event is expected to draw over 100,000 people of all ages, and is a major highlight of the summer entertainment schedule at Jones Beach, which has played host to family-friendly festivities and activities since it opened in 1929.

Fireworks begin at 9:30 PM at the Central Mall, with music during the colorful and patriotic show to be simulcast by WALK 97.5 FM and K-98.3 FM.

Trending Stock Analyst Review: LifePoint Health Inc (NASDAQ:LPNT)

The shares of LifePoint Health Inc (NASDAQ:LPNT) currently has mean rating of 2.50 while 4 analysts have recommended the shares as “BUY”, 4 recommended as “OUTPERFORM” and 13 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 1.61 billion by 18 analysts. The means estimate of sales for the year ending Dec-16 is 6.49 billion by 19 analysts.

The mean price target for the shares of LifePoint Health Inc (NASDAQ:LPNT) is at 77.61 while the highest price target suggested by the analysts is 94.00 and low price target is 61.50. The mean price target is calculated keeping in view the consensus of 19 brokerage firms.

The average estimate of EPS for the current fiscal quarter for LifePoint Health Inc (NASDAQ:LPNT) stands at 0.91 while the EPS for the current year is fixed at 3.75 by 22 analysts.

The next one year’s EPS estimate is set at 4.35 by 21 analysts while a year ago the analysts suggested the company’s EPS at 3.75. The analysts also projected the company’s long-term growth at 7.38% for the upcoming five years.

In its latest quarter ended on 31st March 2016, LifePoint Health Inc (NASDAQ:LPNT) reported earnings of $0.87. The posted earnings missed the analyst’s consensus by -$0.01 with the surprise factor of -1.10%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals offer a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric services, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. The company’s hospitals also provide various outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. In addition, it owns and operates schools of nursing and other allied health professions. As of December 31, 2015, the company operated 67 hospitals campuses in 21 states. The company was formerly known as LifePoint Hospitals, Inc. and changed its name to LifePoint Health, Inc. in May 2015. LifePoint Health, Inc. was founded in 1997 and is based in Brentwood, Tennessee.

Stock in Limelight: Enova International Inc (NYSE:ENVA)

The shares of Enova International Inc (NYSE:ENVA) currently has mean rating of 2.60 while Zero analysts have recommended the shares as “BUY”, 2 recommended as “OUTPERFORM” and 3 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending June-16 is 166.38 million by 5 analysts. The means estimate of sales for the year ending Dec-16 is 709.50 million by 5 analysts.

The mean price target for the shares of Enova International Inc (NYSE:ENVA) is at 8.85 while the highest price target suggested by the analysts is 10.00 and low price target is 8.00. The mean price target is calculated keeping in view the consensus of 5 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Enova International Inc (NYSE:ENVA) stands at 0.23 while the EPS for the current year is fixed at 0.93 by 3 analysts.

The next one year’s EPS estimate is set at 1.07 by 4 analysts while a year ago the analysts suggested the company’s EPS at 0.93.

In its latest quarter ended on 31st March 2016, Enova International Inc (NYSE:ENVA) reported earnings of $0.30. The posted earnings topped the analyst’s consensus by $0.09 with the surprise factor of 42.90%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 20, 2016 Enova International Inc (ENVA) announced that Steve Cunningham is joining the leading financial technology company as Chief Financial Officer. A veteran financial services executive, Cunningham joins Enova from Discover Financial Services, where he most recently served as Executive Vice President and Chief Risk Officer for Discover’s $8.7 billion direct banking and payment services business. Cunningham brings with him an extensive background in corporate finance, treasury, financial planning and analysis, tax, investor relations, capital markets and risk management, along with a shared vision for providing direct lending and financing solutions for consumers and small businesses.

“It is great to have Steve joining Enova at this exciting time as we focus our efforts on growth in our key new initiatives and continue to deliver great results in our proven businesses,” said David Fisher, Enova’s Chief Executive Officer. “Steve’s experience will be essential as we continue to grow.”

“I was attracted to Enova’s entrepreneurial culture,” said Cunningham, “and I am impressed by Enova’s strategy and the clear vision to serve customers and close the world’s credit gap. This is a talented, results-oriented company, and I’m thrilled to be joining the team.”

Cunningham, whose role is effective immediately, will report to Enova CEO David Fisher and will lead all of the company’s financial operations. He will succeed Rob Clifton, who has served as Enova’s CFO since its spin-off from Cash America. Clifton will remain at Enova as Chief Accounting Officer, where his deep knowledge and experience in consumer lending operations will be vital as Enova grows its product and service offerings.

Most recently as Discover’s Chief Risk Officer, Cunningham built the company’s risk organization and was responsible for enterprise risk management, compliance, oversight of credit, and operational, market and liquidity risk, as well as Discover’s capital planning program.

He joined Discover as its Corporate Treasurer in 2010, where he was responsible for developing and executing the company’s liquidity, market risk and capital management strategies. Prior to Discover, Cunningham was the CFO of Harley-Davidson Financial Services, a $7 billion receivables business, and spent eight years at Capital One Financial in various corporate and line of business finance leadership positions, including CFO for the Auto Finance segment, a $20 billion receivables business, and CFO for the company’s banking segment. Cunningham also has experience as a bank regulator with the FDIC, giving him insights into the highly regulated environment in which Enova operates.

Allstate Corp (NYSE:ALL) Stock Price Will Hit 73.21:Analyst

Analysts are weighing in on how Allstate Corp (NYSE:ALL), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.2. The stock is rated as buy by 9 analysts, with 7 outperform and 8 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 18.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.57 a share, which would compare with $0.63 in the same quarter last year. They have a high estimate of $1.16 and a low estimate of $0.10. Revenue for the period is expected to total nearly $8.14B from $7.88B the year-ago period.

For the full year, 20.00 Wall Street analysts forecast this company would deliver earnings of 4.34 per share, with a high estimate of $5.20 and a low estimate of $3.85. It had reported earnings per share of $5.19 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $31.88B versus 30.87B in the preceding year.

The analysts project the company to maintain annual growth of around 11.11% percent over the next five years as compared to an average growth rate of 9.30% percent expected for its competitors in the same industry.

Among the 19 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for ALL is $73.21 but some analysts are projecting the price to go as high as $80.00. If the optimistic analysts are correct, that represents a 18 percent upside potential from the recent closing price of $67.86. Some sell-side analysts, particularly the bearish ones, have called for $64.00 price targets on shares of Allstate Corp (NYSE:ALL).

In the last reported results, the company reported earnings of $0.63 per share, while analysts were calling for share earnings of $0.97. It was an earnings surprise of -35.10%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

The Allstate Corporation, together with its subsidiaries, engages in property-liability insurance and life insurance business in the United States and Canada. The companys Allstate Protection segment sells private passenger auto, homeowners, and other property-liability insurance products under the Allstate, Esurance, and Encompass brand names. It also offers specialty auto products including motorcycle, trailer, motor home, and off-road vehicle insurance policies; other personal lines products including renter, condominium, landlord, boat, umbrella, and manufactured home insurance policies; commercial lines products for small business owners; roadside assistance products; service contracts; and other products sold in conjunction with auto lending and vehicle sales transactions. In addition, this segment sells its products through contact centers and Internet. The companys Allstate Financial segment provides traditional, interest-sensitive, and variable life insurance; and voluntary accident and health insurance products; deferred and immediate fixed annuities; and funding agreements backing medium-term notes; and retirement and investment products, including mutual funds, fixed and variable annuities, disability insurance, and long-term care insurance. This segment markets its products through its agencies and financial specialists, and workplace enrolling independent agents. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Analyst Activity: Capital One Financial Corp. (NYSE:COF)

Analysts are weighing in on how Capital One Financial Corp. (NYSE:COF), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.4. The stock is rated as buy by 8 analysts, with 6 outperform and 11 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 25.00 analysts offering adjusted EPS forecast have a consensus estimate of $1.89 a share, which would compare with $1.50 in the same quarter last year. They have a high estimate of $2.00 and a low estimate of $1.78. Revenue for the period is expected to total nearly $6.28B from $5.67B the year-ago period.

For the full year, 27.00 Wall Street analysts forecast this company would deliver earnings of 7.54 per share, with a high estimate of $7.80 and a low estimate of $7.15. It had reported earnings per share of $7.07 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $25.48B versus 23.41B in the preceding year.

The analysts project the company to maintain annual growth of around 5.13% percent over the next five years as compared to an average growth rate of 10.88% percent expected for its competitors in the same industry.

Among the 23 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for COF is $81.28 but some analysts are projecting the price to go as high as $108.00. If the optimistic analysts are correct, that represents a 65 percent upside potential from the recent closing price of $65.60. Some sell-side analysts, particularly the bearish ones, have called for $59.00 price targets on shares of Capital One Financial Corp. (NYSE:COF).

In the last reported results, the company reported earnings of $1.50 per share, while analysts were calling for share earnings of $1.97. It was an earnings surprise of -23.90%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Capital One Financial Corporation operates as the bank holding company for the Capital One Bank (USA), National Association (COBNA); and Capital One, National Association (CONA), which provide various financial products and services in the United States, the United Kingdom, and Canada. It operates through three segments: Credit Card, Consumer Banking, and Commercial Banking. The company offers various non-interest bearing and interest-bearing deposits, such as demand deposits, money market deposits, time deposits, negotiable order of withdrawal accounts, and savings accounts. It also provides credit card loans and installment loans; auto, home, and retail banking loans; and commercial and multifamily real estate, commercial and industrial, and small-ticket commercial real estate loans. In addition, the company offers credit and debit card products; online direct banking services; and treasury management and depository services. It serves consumers, small businesses, and commercial clients through the Internet and other distribution channels, as well as through branches located in New York, Louisiana, Texas, Maryland, Virginia, New Jersey, and the District of Columbia. The company was founded in 1993 and is headquartered in McLean, Virginia. Capital One Financial Corporation (NYSE:COF) operates independently of Signet Banking Corp. as of February 28, 1995.

Analyst Activity: First Horizon National Corp (NYSE:FHN)

Analysts are weighing in on how First Horizon National Corp (NYSE:FHN), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.8. The stock is rated as buy by 5 analysts, with 0 outperform and 11 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 17.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.23 a share, which would compare with $0.22 in the same quarter last year. They have a high estimate of $0.24 and a low estimate of $0.21. Revenue for the period is expected to total nearly $313.36M from $296.94M the year-ago period.

For the full year, 18.00 Wall Street analysts forecast this company would deliver earnings of 0.92 per share, with a high estimate of $0.97 and a low estimate of $0.85. It had reported earnings per share of $0.81 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $1.26B versus 1.17B in the preceding year.

The analysts project the company to maintain annual growth of around 7.00% percent over the next five years as compared to an average growth rate of 8.20% percent expected for its competitors in the same industry.

Among the 15 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for FHN is $14.77 but some analysts are projecting the price to go as high as $16.00. If the optimistic analysts are correct, that represents a 13 percent upside potential from the recent closing price of $14.10. Some sell-side analysts, particularly the bearish ones, have called for $12.00 price targets on shares of First Horizon National Corp (NYSE:FHN).

In the last reported results, the company reported earnings of $0.22 per share, while analysts were calling for share earnings of $0.20. It was an earnings surprise of 10.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

First Horizon National Corporation operates as the bank holding company for First Tennessee Bank National Association that provides various financial services in the United States and internationally. The company offers general banking services for consumers, businesses, financial institutions, and governments. It also provides investments, financial planning, trust, asset management, credit card, and cash management services. In addition, the company is involved in fixed income securities sales, trading, and strategies for institutional clients; underwriting of bank-eligible securities and other fixed-income securities eligible for underwriting by financial subsidiaries; loan sales; derivative sales; and provision of portfolio advisory services. Further, it offers discount brokerage and full-service brokerage; correspondent banking services; transaction processing services comprising nationwide check clearing services and remittance processing; trust, fiduciary, and agency services; credit card products; equipment finance; and investment and financial advisory services. Additionally, the company engages in mutual fund and retail insurance sales, as well as provides mortgage banking services. As of December 31, 2015, it had 185 branch locations in 8 states, including 166 branches in Tennessee; 2 branches in northwestern Georgia; 6 branches in northwestern Mississippi; 7 branches in North Carolina; and 1 branch each in Virginia, South Carolina, Florida, and Texas. The company was founded in 1968 and is headquartered in Memphis, Tennessee.